Medimaging Integrated Solution (TPE:6796) EBIT: NT$26.0 Mil (TTM As of Dec. 2025)


TPE:6796 Medimaging Integrated Solution Inc TPE:6796
73 GF Score
Price NT$58.00
GF Value NT$106.34
Valuation Significantly Undervalued
! 9 Warning Signs
View Full Analysis

What is Medimaging Integrated Solution EBIT?

Medimaging Integrated Solution TPE:6796 -2.03% 73 EBIT is NT$26.0 Mil as of Dec. 2025. GuruFocus rates TPE:6796 with a GF Score™ of 73/100 and a GF Value™ of NT$106.34 (Significantly Undervalued). The stock has 9 warning signs investors should review.

Medimaging Integrated Solution's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was NT$44.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$26.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medimaging Integrated Solution's annualized ROC % for the quarter that ended in Dec. 2025 was 11.31%. Medimaging Integrated Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 23.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medimaging Integrated Solution's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.06%.


Medimaging Integrated Solution  (TPE:6796) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medimaging Integrated Solution's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=124.94 * ( 1 - 18.46% )/( (892.611 + 908.385)/ 2 )
=101.876076/900.498
=11.31 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1348.257 - 122.356 - ( 362.536 - max(0, 460.414 - 793.704+362.536))
=892.611

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1571.704 - 116.751 - ( 546.568 - max(0, 455.263 - 1027.957+546.568))
=908.385

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Medimaging Integrated Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=178.152/( ( (486.454 + max(236.487, 0)) + (476.254 + max(297.568, 0)) )/ 2 )
=178.152/( ( 722.941 + 773.822 )/ 2 )
=178.152/748.3815
=23.80 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(134.011 + 234.235 + 24.917) - (122.356 + 0 + 34.32)
=236.487

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(174.776 + 246.085 + 26.528) - (116.751 + 0 + 33.07)
=297.568

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medimaging Integrated Solution's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=26.037/2460.217
=1.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medimaging Integrated Solution EBIT Related Terms


Medimaging Integrated Solution EBIT Historical Data

* Premium members only.

The historical data trend for Medimaging Integrated Solution's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medimaging Integrated Solution EBIT Chart

Medimaging Integrated Solution Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 81.94 88.83 96.83 20.82 26.04

Medimaging Integrated Solution Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.14 8.42 -33.42 6.49 44.54

TPE:6796 vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Medimaging Integrated Solution's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medimaging Integrated Solution EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medimaging Integrated Solution's EV-to-EBIT falls into.


TPE:6796
73GF Score
Medimaging Integrated Solution Inc TPE:6796
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medimaging Integrated Solution EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$26.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NT$26.0 Mil mean?
Medimaging Integrated Solution (TPE:6796) has a EBIT of NT$26.0 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medimaging Integrated Solution.
Is Medimaging Integrated Solution's EBIT too high?
Medimaging Integrated Solution's current EBIT is NT$26.0 Mil. Overall, Medimaging Integrated Solution has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's EBIT compare to ABT and SYK?
Medimaging Integrated Solution's EBIT of NT$26.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medimaging Integrated Solution. Medimaging Integrated Solution's current EBIT is NT$26.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.34, compared to a current price of NT$58.00 — trading 45.5% below its estimated fair value. The current EBIT is NT$26.0 Mil. Medimaging Integrated Solution's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current EBIT is NT$26.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?

Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued. The current stock price of NT$58.00 is trading 45.5% below its estimated GF Value™ of NT$106.34. GuruFocus considers Medimaging Integrated Solution to be Significantly Undervalued.

Key valuation signals for TPE:6796:

  • EBIT: NT$26.0 Mil
  • GF Value™: NT$106.34 vs. price of NT$58.00 (45.5% below fair value)
  • GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medimaging Integrated Solution Business Description

Address No.24-2, Industry E. Road IV, 3rd Floor, Hsinchu Science Park, Hsinchu, TWN, 30077
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
73GF Score

Get the complete analysis for TPE:6796

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$58.00
Price
NT$106.34
GF Value